Clinical Trials Logo

Sleep Deprivation clinical trials

View clinical trials related to Sleep Deprivation.

Filter by:

NCT ID: NCT04601519 Recruiting - Type 1 Diabetes Clinical Trials

Effect of Type 1 Diabetes on Sleep Fragmentation

DIAPASOM5
Start date: July 1, 2021
Phase:
Study type: Observational

The main objective of this study is the objective evaluation of disease related sleep fragmentation in subjects with type 1 diabetes.

NCT ID: NCT04399200 Recruiting - Stroke Clinical Trials

Apnea, Stroke and Incident Cardiovascular Events

ASCENT
Start date: July 13, 2020
Phase:
Study type: Observational

This prospective cohort study aims to compare the proportion of cardiac or cerebrovascular events after a first stroke, a first transient ischemic attack (TIA) or recurrent TIA, between sleep-disordered breathing (SDB) and non-SDB (control) patients, one year after SDB diagnosis, performed 3 months after stroke onset. The primary outcome is a composite endpoint composed of cardiac or cerebrovascular events regrouping: death from any cardiac or cerebrovascular cause, non-fatal stroke, and non-fatal acute coronary disease. 1620 patients, in the acute phase of a first stroke, TIA or recurrent TIA will be included in the cohort. Clinical, neuroimaging, sensorimotor, cognitive and biological parameters will be collected at inclusion. Three months after stroke or TIA onset, polysomnography will be performed for SDB diagnosis. Patients will be considered as having SDB for an Apnea-Hypopnea Index (AHI) > 15 events/hour, or to the control group otherwise. The same clinical, imaging, cognitive and biological assessments than during the first visit will be performed; incident (new) cardiovascular events will be collected. Three months later, and at 1, 2, 3, 4 and 5 years after SDB diagnosis, the same clinical, cognitive, sensorimotor, and sleep-related evaluations will be performed. In addition to the aforementioned parameters, incident cardiovascular outcomes will be collected, at the same time points. The primary study outcome will be retrieved one year after stroke onset.

NCT ID: NCT04279834 Recruiting - Hypertension Clinical Trials

Improving Outcomes for Patients With SDB and Insufficient Sleep

RESTORE
Start date: October 16, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to look at how sleep disordered breathing (SDB) and not getting enough sleep each night contribute to daytime sleepiness. The investigators also want to determine the treatment that works best for improving daytime sleepiness. In this study, the investigators are comparing 2 programs that may improve symptoms of daytime sleepiness.

NCT ID: NCT04214184 Recruiting - Sleep Deprivation Clinical Trials

Biomarkers of Increased Free Living Sleep Time

Start date: December 2, 2019
Phase: N/A
Study type: Interventional

This protocol will increase sleep duration in participants who maintain less than 6 hours sleep per night, to target the recommended 7 hours of sleep per night. The focus of this study is determine how increasing nightly sleep duration in these individuals who maintain less than 6 hours sleep per night changes their plasma metabolome and insulin sensitivity. The primary outcome will examine changes in branched-chain amino acids and the secondary outcome will examine changes in insulin sensitivity. The investigators will also determine if changes in plasma metabolites can be used as a biomarker to discriminate between adequate versus insufficient sleep.

NCT ID: NCT04092894 Recruiting - Insomnia Clinical Trials

Suvorexant and Sleep/Delirium in ICU Patients

Start date: February 28, 2020
Phase: Phase 4
Study type: Interventional

Investigators will evaluate the efficacy of postoperative oral suvorexant treatment on nighttime wakefulness after persistent sleep onset (WASO) among adult cardiac surgical patients recovering in the cardiac intensive care unit (ICU). The study include patients ≥ 60 years old undergoing coronary artery bypass graft surgery (CABG), with or without valve surgery (aortic or mitral). Patients will receive either oral suvorexant or placebo for 7 nights starting the night after extubation. The primary hypothesis is that suvorexant compared with placebo decreases WASO, as measured by a specialized electroencephalogram (EEG), the SedLine monitor, during the first night in the cardiac ICU. Investigators will also assess total sleep time (TST), time to sleep onset (TSO), and postoperative delirium and delirium-free days.

NCT ID: NCT03843645 Recruiting - Surgery Clinical Trials

General Versus Regional Anesthesia and Postoperative Sleep Quality

AnesthSleep
Start date: February 10, 2019
Phase: N/A
Study type: Interventional

Major surgery can lead to postoperative disturbances in sleep patterns with subjective deterioration of sleep quality according to patients' reports as well as objective alterations of sleep architecture, as recorded by polysomnography Factors implicated in postoperative sleep disturbances include but are not limited to the severity of the surgical procedure, the neuroendocrine response to surgery, inadequate treatment of postoperative pain and external factors interfering with sleep, such as light, noise and therapeutic procedures There are no adequate data from current literature as to whether regional anesthesia is superior to general anesthesia regarding postoperative sleep quality in patients subjected to either mode of anesthesia. So, the aim of this study will be to assess the effect of two different anesthetic techniques (general versus regional) in patients subjected to similar operations Patients will be assessed with the Pittsburgh Sleep Quality Questionnaire (PSQI), regarding preoperative and long term postoperative sleep quality and sleep diaries regarding early postoperative sleep quality

NCT ID: NCT03767426 Recruiting - Sleep Clinical Trials

The Effect of Sleep Deprivation and Recovery Sleep on Emotional Memory and Affective Reactivity

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

To further understand the impact of acute sleep deprivation and recovery sleep on the processing of emotional information the investigators will address and attempt to answer three questions, (i) how both undisturbed sleep and sleep deprivation affect the processing and retrieval of emotional information, (ii) what neural and psychophysiological mechanisms are associated with these behavioral effects, and (iii) to explore the ability of recovery sleep to reverse the effects of sleep deprivation. Together, these studies will provide a greater breadth and depth of knowledge concerning sleep's role in emotion processing and regulation. Given the growing societal tendency to view sleep as unproductive-foregoing it to lengthen work days and increase social opportunities- such knowledge would be of practical importance for understanding the role of sleep in healthy emotional functioning, particular for individuals experiencing periods of increased stress and emotional distress (e.g., new parents, hospital staff, or combat troops).

NCT ID: NCT03747367 Recruiting - Stress Clinical Trials

The Microbiome and Resilience to Sleep and Circadian Disruption

Start date: October 21, 2015
Phase: N/A
Study type: Interventional

This study is about how sleep loss and being awake at night impacts the ability to think, changes molecules in the blood, and alters the bacteria that live in the gut that typically help keep people healthy. This work will have important implications for the development of treatments and countermeasures for people who do not sleep enough and need to be active at different times of the day and night (e.g., emergency workers and military personnel).

NCT ID: NCT03708341 Recruiting - Sleep Deprivation Clinical Trials

Exogenous Melatonin in Intensive Care Unit Chronodisruption

EMIC
Start date: November 15, 2018
Phase: Phase 3
Study type: Interventional

To this day, a small number of studies have evaluated the effect of melatonin on the modifications of the characteristics of sleep in critical care units, with mostly a small studied population. However, no study has been realized on a large population, nor has it evaluated the association between genetic factors and response to treatment (melatonin), hence the originality of our study. In our study we hypothesized that systematic melatonin usage in ICU can ameliorate the total sleep time and the fragmentation index and can decrease the confusion related to sleep deprivation.

NCT ID: NCT03693651 Recruiting - Parenting Clinical Trials

Study of the Quality of Sleep of Parents of Premature Children Compared to Parents of Full-term Children

SLEEP-PP
Start date: June 14, 2018
Phase:
Study type: Observational

This study evaluate the incidence of sleep disorders in parents of premature children hospitalized in unit care of neonatalogy or intensive unit care of neonatalogy, compared to parents of full-term child in maternity.